BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 16183515)

  • 41. Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
    Miceli MH; Maertens J
    Semin Respir Crit Care Med; 2015 Oct; 36(5):650-61. PubMed ID: 26398532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Utility of Aspergillus-LFD: first experience in Chile].
    Alvarez E
    Rev Chilena Infectol; 2015 Feb; 32(1):117-9. PubMed ID: 25860056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current approaches to diagnosis and treatment of invasive aspergillosis.
    Segal BH; Walsh TJ
    Am J Respir Crit Care Med; 2006 Apr; 173(7):707-17. PubMed ID: 16387806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.
    Lass-Flörl C; Gunsilius E; Gastl G; Bonatti H; Freund MC; Gschwendtner A; Kropshofer G; Dierich MP; Petzer A
    J Clin Microbiol; 2004 Sep; 42(9):4154-7. PubMed ID: 15365004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Galactomannan and polymerase chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia.
    Chambon-Pautas C; Costa JM; Chaumette MT; Cordonnier C; Bretagne S
    J Infect; 2001 Oct; 43(3):213-4. PubMed ID: 11798263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation.
    Busca A; Locatelli F; Barbui A; Limerutti G; Serra R; Libertucci D; Falda M
    Transplant Proc; 2006 Jun; 38(5):1610-3. PubMed ID: 16797366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen.
    Oren I; Avidor I; Sprecher H
    Transpl Infect Dis; 2012 Feb; 14(1):107-9. PubMed ID: 21733049
    [No Abstract]   [Full Text] [Related]  

  • 49. Current challenges in the microbiological diagnosis of invasive aspergillosis.
    Guinea J; Bouza E
    Mycopathologia; 2014 Dec; 178(5-6):403-16. PubMed ID: 24947167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the diagnostic value of the measurement of (1-->3)-beta-D-glucan in patients with pulmonary aspergillosis.
    Yuasa K; Goto H; Iguchi M; Okamura T; Ieki R
    Respiration; 1996; 63(2):78-83. PubMed ID: 8966370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aspergillus galactomannan detection: Trichoderma as a cause of positive results.
    Markantonatou AM; Samaras K; Yannaki E; Zachrou E; Vyzantiadis TA
    Curr Microbiol; 2019 Jan; 76(1):48-51. PubMed ID: 30310968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Diagnostic Testing for Aspergillus.
    Powers-Fletcher MV; Hanson KE
    J Clin Microbiol; 2016 Nov; 54(11):2655-2660. PubMed ID: 27487954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving the rates of Aspergillus detection: an update on current diagnostic strategies.
    Jenks JD; Salzer HJF; Hoenigl M
    Expert Rev Anti Infect Ther; 2019 Jan; 17(1):39-50. PubMed ID: 30556438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Invasive aspergillosis diagnosed by immunohistochemistry with monoclonal and polyclonal reagents.
    Phillips P; Weiner MH
    Hum Pathol; 1987 Oct; 18(10):1015-24. PubMed ID: 3308679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.
    Huppler AR; Fisher BT; Lehrnbecher T; Walsh TJ; Steinbach WJ
    J Pediatric Infect Dis Soc; 2017 Sep; 6(suppl_1):S32-S44. PubMed ID: 28927202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspergillus serology: Have we arrived yet?
    Richardson MD; Page ID
    Med Mycol; 2017 Jan; 55(1):48-55. PubMed ID: 27816904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Update in the diagnostic and therapeutic approach of invasive aspergillosis in adult population].
    Rabagliati R
    Rev Chilena Infectol; 2018; 35(5):531-544. PubMed ID: 30725000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infections with Aspergillus species.
    Andriole VT
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S481-6. PubMed ID: 8274614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomarkers of fungal infection: Expert opinion on the current situation.
    Bouza E; Almirante B; García Rodríguez J; Garnacho-Montero J; Salavert M; Muñoz P; Sanguinetti M
    Rev Esp Quimioter; 2020 Feb; 33(1):1-10. PubMed ID: 31729203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-date on diagnostic strategies of invasive aspergillosis.
    Lackner M; Lass-Flörl C
    Curr Pharm Des; 2013; 19(20):3595-614. PubMed ID: 23278540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.